Clinical trials are both a treatment option for all types of patients and the core way that new advances are made in AML care. Learn more about these clinical trials.
Better tolerated and more effective therapies are needed for the treatment of AML.
E-selectin is a biomarker that is currently being investigated for its efficacy in AML treatment.
Recent findings from a Phase 3 study “resulted in the disappearance of all signs of cancer from treatment for six months."
Explore the significance of clinical trials and their impact on an AML cure.
When treating AML, a stem cell transplant is generally the most successful treatment option.
HealthTree spoke with Dr. Jamy at ASCO 2023 about his open clinical trial utilizing a new vaccine therapy for non-transplant eligible AML patients.
Let's review 5 important clinical trials for patients with AML.
Briquilimab has shown it is a safe and well-tolerated conditioning agent for older patients receiving an allogeneic hematopoietic cell transplantation.
Ellipses Pharma is a drug company that works to accelerate cancer treatment through innovative drug models.
Phase 2 of the KOMET-001 trial has dosed its first set of patients. This is a continuation of a trial testing the efficacy of Ziftomenib.